Knowing origin of broadly neutralizing antibodies could aid universal flu vaccine design
National Institutes of Health scientists have identified how a kind of immature immune cell responds to a part of influenza virus and have traced the path those cells take to generate antibodies that can neutralize a wide ...
Medical research
Aug 29, 2012 |
not rated yet |
0
|
Belimumab for lupus erythematosus: Added benefit not proven
Belimumab (trade name Benlysta) has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). This monoclonal antibody is only considered as treatment ...
Cancer
Aug 29, 2012 |
not rated yet |
0
New hope for spinal cord injury patients
A new antibody could reverse the damage caused by trauma to the central nervous system, according to new research.
Diseases, Conditions, Syndromes
Aug 29, 2012 |
3 / 5 (1) |
0
Double attack on SARS
After the SARS-CoV (severe acute respiratory syndrome coronavirus) outbreak in 2003, academia experts in immunology and molecular biology joined forces with industrial vaccine production experts in order ...
Diseases, Conditions, Syndromes
Aug 28, 2012 |
not rated yet |
0
Targeting sugars in the quest for a vaccine against HIV -- the virus that causes AIDS
As a step toward designing the first effective vaccine against HIV, the virus that causes AIDS, scientists are reporting new insights into how a family of rare, highly potent antibodies bind to HIV and neutralize it — ...
HIV & AIDS
Aug 21, 2012 |
not rated yet |
0
Dual action polyclonal antibody may offer more effective, safer protection against osteoporosis
A new study suggests that a polyclonal antibody that blocks follicle-stimulating hormone (FSH) in mice without ovaries might offer a more effective way to prevent or arrest osteoporosis than currently available treatments.
Medical research
Aug 20, 2012 |
5 / 5 (1) |
0
|
Mepolizumab almost halves exacerbations in patients with severe asthma
The largest study of patients with severe asthma to date, published in the Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50 percent reduct ...
Immunology
Aug 16, 2012 |
not rated yet |
0
Blood markers reveal severity of common kidney disease
Increasing blood levels of particular proteins may act as warning signs for patients with one of the most common diseases of the kidney, according to a study appearing in an upcoming issue of the Journal of the American So ...
Diseases, Conditions, Syndromes
Aug 16, 2012 |
not rated yet |
0
Study suggests potential hurdle to universal flu vaccine development may be overcome
In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing ...
Diseases, Conditions, Syndromes
Aug 15, 2012 |
not rated yet |
0
|
Blood cancer cells initiate signalling cascade
Researchers in the group of Prof. Dr. Hassan Jumaa, Centre for Biological Signalling Studies (BIOSS) of the University of Freiburg, Department for Molecular Immunology, have identified a new mechanism that ...
Cancer
Aug 13, 2012 |
not rated yet |
0
Hepatitis A vaccination in children under two remains effective for ten years
Vaccination against the hepatitis A virus (HAV) in children two years of age and younger remains effective for at least ten years, according to new research available in the August issue of Hepatology, a journal of the Am ...
Diseases, Conditions, Syndromes
Aug 09, 2012 |
5 / 5 (1) |
0
|
Toward 'universal' vaccine: Scientists describe antibodies that protect against large variety of flu viruses
A team led by scientists at The Scripps Research Institute and Crucell Vaccine Institute in the Netherlands describes three human antibodies that provide broad protection against Influenza B virus strains. ...
Medical research
Aug 09, 2012 |
5 / 5 (5) |
0
|
Gum disease four times as common in rheumatoid arthritis patients
Gum disease is not only four times as common among patients with the autoimmune disease rheumatoid arthritis as it is among their healthy peers, but it also tends to be more severe, indicates a small study published online ...
Arthritis & Rheumatism
Aug 08, 2012 |
not rated yet |
0
Clinical trial for rabies monoclonal antibody
A pivotal clinical trial for an anti-rabies human monoclonal antibody (RMAb) being developed through a collaborative partnership between MassBiologics of the University of Massachusetts Medical School and the Serum Institute ...
Diseases, Conditions, Syndromes
Aug 07, 2012 |
not rated yet |
0
Adalimumab is a promising therapy for children with Crohn's disease
Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the official journal of the ...
Diseases, Conditions, Syndromes
Aug 06, 2012 |
not rated yet |
0
